You are here: Industry Insights > GSK

News List

Gavi to award $75 million to Serum Institute of India for introduction of the pneumonia vaccine in d expresspharma
June 05, 2020
Until now, the only two producers of the pneumonia vaccine have been Pfizer and GlaxoSmithKline (GSK).
GSK plans to produce one billion pandemic vaccine adjuvant doses pharmaceutical-technology
June 01, 2020
GlaxoSmithKline (GSK) is set to produce one billion doses of its pandemic vaccine adjuvant system next year to support adjuvanted Covid-19 vaccine candidates development.
GSK says science does not link pandemic H1N1 flu vaccine to sleep disorder expresspharma
May 29, 2020
A spokesman for GSK said the “science has moved on” since concerns were raised about links between narcolepsy and its H1N1 vaccine, called Pandemrix, which was developed during the flu pandemic 10 years ago.
GSK Partners with Samsung Biologics contractpharma
May 28, 2020
Inks $231 million deal to secure additional manufacturing capacity for biopharmaceutical portfolio.
GSK’s long-acting injection beats Truvada in HIV prevention trial expresspharma
May 19, 2020
Truvada generated $2.8 billion in sales last year, both from treatment and preventing an HIV infection.
GSK reports revenue growth at 3 per cent in quarter financial results expresspharma
May 19, 2020
Board of Directors of the Company recommends a Dividend of Rs. 40 per equity share (including special dividend of Rs. 20 per equity share) for the 12 months period ended March 31, 2020.
GSK books 19% sales growth for first quarter pharmatimes
May 05, 2020
GlaxoSmithKline has reported 19% growth in group sales to £9.1 billion for the first quarter.
Sanofi and GSK partner to develop Covid-19 vaccine pharmaceutical-technology
April 15, 2020
Sanofi and GlaxoSmithKline (GSK) have signed a letter of intent for a partnership focused on developing an adjuvanted vaccine for Covid-19.
COVID-19 Testing Collaboration: AstraZeneca & GSK contractpharma
April 10, 2020
Big Pharma firms and the University of Cambridge collaborate to support UK national effort to boost COVID-19 testing.
GSK’s asthma drug Nucala meets co-primary endpoints in SYNAPSE trial pharmaceutical-business-review
April 08, 2020
GlaxoSmithKline (GSK) said that its asthma drug Nucala (mepolizumab) has succeeded in the phase 3 SYNAPSE trial in patients with nasal polyps associated with chronic rhinosinusitis (CRSwNP).

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page